10
Participants
Start Date
December 5, 2023
Primary Completion Date
May 8, 2025
Study Completion Date
May 8, 2025
UTAA06 injection for treatment of advanced malignant solid tumors
The subjects who sign the informed consent forms and been screened by inclusion/exclusion criteria,will be assigned into 1×10\^8CAR+gdT、3×10\^8CAR+gdT、5×10\^8CAR+gdT、8×10\^8CAR+gdT、1×10\^9CAR+gdT groups inder of sequence.And the subjects will be administered once.
PersonGen Anke Cellular Therapeutice Co.,Ltd, Hefei
Peking University
OTHER